BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Caps

How do you think BMRN will perform against the market?

Add Stock to CAPS Watchlist

All Players

917 Outperform
55 Underperform
 

All-Star Players

192 Outperform
8 Underperform
 

Wall Street

20 Outperform
1 Underperform
 

Top BMRN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

d3ming (60.95)
Submitted January 31, 2014

zzporte

GundersonGroup (28.17)
Submitted November 05, 2012

The global target market for Morquio syndrome patients with ability to pay for treatment is around 2500 patients. ThinkEquity analyst Kimberly Lee estimates the market potential of GALNS at 575 million annually. This would be $230,000 annually per… More

BMRN VS S&P 500 (SPY)

Fools bullish on BMRN are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about BMRN.

Recs

0
Member Avatar OklaBoston (41.66) Submitted: 12/7/2018 3:11:13 PM : Underperform Start Price: $92.22 BMRN Score: -2.20

Another overvalued eqUity insiders are taking profits on. I wouldn't be surprised if it fell back below $10.00.

Recs

0
Member Avatar TMFEBCapital (64.81) Submitted: 6/7/2018 9:49:55 AM : Outperform Start Price: $92.15 BMRN Score: +7.41

Palynziq could address more PKU patients than BMRN's Kuvan (its second best-seller) and that means 400 mn plus in annual revenue. Mgmt thinks that if it's widely adopted, it's peak sales could be $1 bn. Given BMRN's sales of 1.3 billion in 2017, that represents a significant potential increase that could finally get this company in the black. The big kicker here, though, is the hemophilia A R&D program, which could have data as soon as next year. A win there would revolutionize treatment and potentially, relegate prophylaxis factor VII replacement to the past.

Recs

0
Member Avatar SaintCroix (98.85) Submitted: 1/14/2018 3:14:30 PM : Outperform Start Price: $84.41 BMRN Score: -4.87

These guys have found a cure for hemophilia. 400,000 people with hemophilia in the world. And BioMarin and Spark are going to make this disease gone.

Wow. Kudos. Outperform.

Leaderboard

Find the members with the highest scoring picks in BMRN.

Score Leader

Jmcq88

Jmcq88 (86.56) Score: +758.20

The Score Leader is the player with the highest score across all their picks in BMRN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
BreakerBeth 97.32 5/17/2006 Outperform 5Y $12.26 +659.46% +117.02% +542.45 1 Comment
GlobalTraveler 76.65 3/5/2009 3/17/2010 Outperform 3Y $10.04 +827.39% +285.14% +542.25 0 Comment
kaywonder < 20 3/6/2009 3/8/2010 Outperform 5Y $10.11 +820.97% +287.78% +533.19 0 Comment
vacafun4 96.50 3/6/2009 Outperform 3Y $10.18 +814.64% +288.06% +526.57 0 Comment
makednoc < 20 3/9/2009 2/8/2011 Outperform 3Y $10.29 +804.86% +284.20% +520.66 0 Comment
RBBioContest06 65.03 6/1/2006 Outperform 1Y $13.05 +613.49% +118.93% +494.56 1 Comment
geolitjon < 20 4/6/2009 Outperform 5Y $12.00 +675.92% +215.67% +460.24 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. luke4489 < 20 2/23/2009 Outperform NS $11.80 +689.07% +238.68% +450.39 0 Comment
MellieMel777 68.02 9/29/2006 Outperform 3Y $14.41 +546.15% +106.67% +439.48 1 Comment
DamYankee < 20 9/29/2006 Outperform 1Y $14.41 +546.15% +106.67% +439.48 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackGoldmanSach 74.44 11/10/2014 Outperform NS $86.00 +1.20% -1.86% +3.06 3/7/2016 @ $87.03 0 Comment
TrackWellsFargo 88.38 11/3/2014 Outperform NS $84.23 +10.54% +29.00% -18.45 0 Comment
TrackSunTrustRH 79.11 10/17/2014 Outperform NS $71.33 +30.53% +38.24% -7.70 0 Comment
TrackJanney 85.07 1/3/2013 Outperform NS $52.20 +78.37% +78.42% -0.04 0 Comment
TrackLazardCapit 75.75 8/7/2012 Outperform NS $38.01 +144.96% +85.81% +59.15 0 Comment
TrackUltraLong < 20 7/9/2012 Underperform NS $40.76 +128.43% +92.40% -36.04 1 Comment
TrackUBS 91.95 4/12/2012 Outperform NS $32.87 +183.27% +89.94% +93.32 0 Comment
TrackCanaccord 68.95 3/26/2012 Outperform NS $34.67 +168.56% +85.19% +83.37 0 Comment
TrackBreanMurray 59.30 3/19/2012 Outperform NS $35.56 +161.84% +85.77% +76.07 0 Comment
TrackZacks < 20 2/17/2012 Underperform 3M $36.20 -4.17% +2.51% +6.68 4/30/2012 @ $34.69 1 Comment
tracksummerstree 91.81 10/31/2011 Outperform NS $35.15 +164.89% +104.84% +60.06 0 Comment
TrackZacks < 20 10/17/2011 Underperform 3M $32.87 +3.77% +4.38% +0.61 10/31/2011 @ $34.11 1 Comment
TrackDeutscheSec 86.68 9/28/2011 Outperform NS $32.98 +15.97% +21.03% -5.05 8/27/2012 @ $38.25 0 Comment
TrackRBCCapMkts 84.93 9/16/2011 Outperform NS $30.85 +201.82% +115.89% +85.93 0 Comment
TrackZacks < 20 4/21/2011 Underperform 3M $26.72 -1.05% +1.46% +2.51 5/3/2011 @ $26.44 1 Comment
TrackJimCramer 85.30 10/11/2010 Outperform 3W $21.82 +326.72% +123.29% +203.43 0 Comment
TrackMorganJos 83.81 9/1/2010 Outperform NS $21.00 +22.67% +11.72% +10.95 11/1/2010 @ $25.76 0 Comment
TrackZacks < 20 8/18/2010 Underperform 3M $20.55 +33.33% +11.93% -21.40 12/3/2010 @ $27.40 1 Comment
TrackRothCapital 76.74 2/9/2010 Outperform NS $19.74 +33.18% +26.39% +6.79 5/3/2011 @ $26.29 0 Comment
TrackCollinsStew 73.15 12/9/2009 Outperform NS $17.29 +438.52% +137.70% +300.82 0 Comment
TrackCreditSuiss 88.72 10/30/2009 Outperform NS $17.56 +430.24% +147.62% +282.62 0 Comment
TrackRichAster 97.69 9/30/2009 Outperform NS $18.08 +414.99% +183.30% +231.68 0 Comment
TrackJimCramer 85.30 9/16/2009 Underperform 3W $17.48 +24.83% +9.04% -15.79 10/11/2010 @ $21.82 0 Comment
TrackMorganJos 83.81 4/21/2009 Outperform NS $12.26 +64.19% +37.50% +26.69 1/8/2010 @ $20.13 0 Comment
TrackFTNEquityCa < 20 3/12/2009 Outperform NS $10.24 +222.17% +89.53% +132.64 4/17/2012 @ $32.99 0 Comment
TrackLeerinkSwan 97.99 3/12/2009 Outperform NS $10.36 +798.75% +265.01% +533.74 0 Comment
TrackRothCapital 76.74 2/24/2009 Outperform NS $12.09 +43.34% +44.83% -1.49 10/19/2009 @ $17.33 0 Comment
TrackBreanMurray 59.30 1/9/2009 Outperform NS $19.20 -1.51% +16.52% -18.03 2/8/2010 @ $18.91 0 Comment
trackbenchmark 99.64 1/7/2009 Outperform NS $18.11 -26.28% -12.59% -13.69 2/19/2009 @ $13.35 0 Comment
TrackCitigroup 92.52 11/21/2008 Outperform NS $14.42 +545.70% +246.50% +299.20 0 Comment
TrackZacks < 20 10/29/2008 Outperform 3M $18.01 -34.43% -17.74% -16.68 2/20/2009 @ $11.81 1 Comment
TrackWMBlair 77.39 9/12/2008 Outperform NS $27.29 +241.19% +116.19% +125.00 0 Comment
TrackCollinsStew 73.15 8/21/2008 Outperform NS $25.84 -48.33% -37.24% -11.09 2/19/2009 @ $13.35 0 Comment
TrackSoleil 94.68 8/6/2008 Outperform NS $29.06 +220.41% +110.09% +110.32 0 Comment
TrackUBS 91.95 7/25/2008 Outperform NS $31.78 -14.65% -3.07% -11.58 12/2/2010 @ $27.13 0 Comment
TrackJefferies 83.83 11/6/2007 Outperform NS $28.25 +229.59% +80.89% +148.70 0 Comment
TrackWellsFargo 88.38 10/11/2007 Outperform NS $27.34 -51.17% -49.00% -2.17 2/19/2009 @ $13.35 0 Comment
TrackCitigroup 92.52 9/28/2007 Outperform NS $24.14 +38.82% -11.38% +50.19 6/12/2008 @ $33.51 0 Comment
TrackZacks < 20 8/9/2007 Outperform 3M $21.48 -5.07% -32.04% +26.96 10/20/2008 @ $20.39 1 Comment
TrackFerrisBaker < 20 7/26/2007 Outperform NS $18.37 +79.59% -7.63% +87.22 4/17/2012 @ $32.99 0 Comment
TrackAGEdwards < 20 2/16/2007 Outperform NS $20.30 -9.60% +5.90% -15.51 6/1/2007 @ $18.35 0 Comment
TrackRodmanRen < 20 12/19/2006 Outperform NS $16.82 +453.57% +95.48% +358.08 0 Comment
TrackBroadpointAmTech < 20 10/10/2006 Outperform NS $16.09 +105.03% +2.20% +102.84 4/17/2012 @ $32.99 0 Comment
TrackRWBaird 87.12 10/2/2006 Outperform NS $15.00 +520.73% +107.07% +413.66 0 Comment
TrackJimCramer 85.30 5/25/2006 Outperform 3W $13.00 +34.46% -16.67% +51.13 9/17/2009 @ $17.48 0 Comment

Advertisement